肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

乳腺癌新辅助化疗:手术效果与预后影响评估

Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis

原文发布日期:26 June 2024

DOI: 10.3390/cancers16132332

类型: Article

开放获取: 是

 

英文摘要:

The correlation between TNM staging and histology variations in a sample of patients who underwent neoadjuvant chemotherapy demonstrates a positive impact on both increasing conservative surgery and achieving pCR, resulting in better outcomes in terms of disease-free survival (DFS) and the risk of relapse. Benefits have also been highlighted in terms of cosmetic outcomes, postoperative complications, and psychological benefits. However, the overall outcomes must be evaluated according to the subtype and individual characteristics of the patients.

 

摘要翻译: 

在接受新辅助化疗的患者样本中,TNM分期与组织学变异之间的相关性显示,其对增加保守手术和实现病理完全缓解均具有积极影响,从而在无病生存期和复发风险方面带来更好的结果。此外,在美容效果、术后并发症及心理获益方面也显示出优势。然而,总体结果仍需根据患者的亚型及个体特征进行评估。

 

原文链接:

Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis

广告
广告加载中...